E-cigarette Harm Reduction Among PLWHA in South Africa

Launched by NYU LANGONE HEALTH · Dec 4, 2023

Keywords

ClinConnect Summary

This clinical trial, called "E-cigarette Harm Reduction Among People Living with HIV/AIDS (PLWHA) in South Africa," is looking for ways to help people who smoke regular cigarettes reduce their tobacco use. The study will compare two methods: using e-cigarettes and nicotine replacement therapy (like patches or gum), enhanced with supportive text messages. By focusing on people living with HIV/AIDS, the goal is to find effective strategies that can improve their health and help them live longer, especially since smoking can be more harmful for them.

To participate, you must be an adult smoker who is living with HIV/AIDS and speaks Afrikaans, Xhosa, or English. You should be smoking at least five cigarettes a day and be interested in reducing your cigarette use, even if you're not ready to quit completely. Participants will be required to have a mobile phone, as the program will use text messaging to provide support. This trial is not yet recruiting, but it aims to build better resources for helping smokers in South Africa through innovative telehealth approaches.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult PLWHA CC smokers;
• • Speaks Afrikaans, or Xhosa, or English;
• • reports daily CC smoking (≥ 5 CPD);
• • Owns any type of mobile phone;
• • interested in reducing CC smoking but not necessarily trying to quit;
• • Receives HIV/AIDS care in one of the eight selected clinics follow-up rates.
• Exclusion Criteria:
• • are pregnant or breastfeeding;
• • unable to provide consent;
• • used tobacco products other than CC in the past 2 weeks (e.g., EC, cigarillo);
• • currently engaged in an attempt to quit CC smoking;
• • current major depressive or manic episode, current psychotic disorder, past-year suicide attempt, or current suicidal ideation with plan or intent. plan or intent.